SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as investors monitor ongoing legislative developments and institutional interest, with the community actively debating the potential impact of regulatory clarity on future utility. Market sentiment remains split between bullish long-term optimism driven by real-world adoption and cautious skepticism regarding supply dynamics and recent price volatility.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is experiencing heavy volatility following strong quarterly earnings, as investors react to management's comments on search traffic volatility and concerns over user growth sustainability in an AI-driven search landscape. While many in the community view the post-earnings sell-off as an exaggerated reaction to short-term search trends and are actively buying the dip, others are debating the platform's long-term reliance on external traffic and expressing frustration with moderation policies.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently in the spotlight as investors weigh its aggressive expansion into the humanoid robotics and physical AI markets against recent mixed delivery results. While some market participants express frustration over price volatility and persistent downward pressure on Chinese EV equities, others highlight the company's long-term potential, citing its advanced driver-assistance technology and potential for future profit from strategic licensing partnerships.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors react to the arrival of significant power infrastructure, including natural gas turbines for its Project Matador campus. Community sentiment is divided between optimism regarding potential tenant signings and performance incentives for executives, and skepticism stemming from the company's recent share offerings and lack of confirmed revenue.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is seeing heavy community discussion around its recent volatility, with bulls highlighting the stock's role in critical U.S. infrastructure and energy projects while bears point to persistent debt concerns and management skepticism. Investors are closely monitoring the potential for a short squeeze alongside speculation regarding strategic partnerships and the company's ability to capitalize on elevated steel prices.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix Inc. is trending as investors debate the impact of the post-TDAPA reimbursement landscape alongside the company's recent strategic portfolio expansion and institutional accumulation. The community remains divided, with active discussions focusing on the long-term adoption of DefenCath, the potential for legislative catalysts, and persistent frustration regarding the stock's recent price volatility.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is seeing significant market debate as investors weigh the stock's long-term enterprise AI potential against technical chart patterns that suggest near-term volatility and potential downside risk. Community discussions are heavily focused on navigating macroeconomic headwinds and anticipating guidance updates in the upcoming earnings report, with some participants eyeing lower entry points while others emphasize the stock's historical recovery resilience.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is currently trending as investors debate the impact of the ziltivekimab Phase 3 trial failure against the backdrop of the company's dominant GLP-1 position. While some stakeholders are concerned about pipeline strength and aggressive sell-offs, the community remains heavily focused on upcoming earnings and the potential for a rebound driven by Wegovy's record sales growth.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

XLV is trending as investors rotate into healthcare, viewing the sector as a defensive hedge amid broader market volatility and uncertainty. Community discussions are heavily focused on high-probability setup opportunities, with traders utilizing Elliott Wave analysis to navigate consolidations and identify technical support levels for risk-managed entries.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc. is trending sharply downward following the release of harshly critical FDA briefing documents that challenge the efficacy and trial design of its melanoma therapy, RP1. Investors are now bracing for the upcoming advisory committee meeting, with community discussion deeply divided between those betting on a potential 'Right to Try' regulatory override and those expecting a third rejection based on the agency's data integrity concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
